Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Būtiski notikumi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2011-04-15 09:12:17 |
Versijas komentārs | |
Teksts |
Olaine, April 15, 2011
“Olainfarm” to supply anti-tuberculosis
medication to the World Health Organisation
At the end of March AS „Olainfarm” became the first
post-soviet producer of pharmaceuticals to have its product
included in the list of prequalified medicines of the World Health
Organisation (WHO). Anti-tuberculosis medicine Para amino
salicylic acid – sodium salt (PASA) has been included in WHO
programme for countries with high incidence of
tuberculosis. This means that the company can sell this
medication to the relevant programmes of WHO without separate
market authorisation for particular countries. Within this
programme Olainfarm has already been awarded a first order of
received a first order of PASA worth 1.4 million US
dollars.
“Being prequalified for this WHO programme is the
highest possible appreciation of quality of Olainfarm’s
products. It opens new sales market for this anti-tuberculosis
medicine. We are glad that the process of assessing production
quality of Olainfarm that has lasted for four years has ended with
such result, and it has been confirmed that in quality terms we are
in the same league with pharmaceutical giants like
“GlaxoSmithKline”, “Roche”, “Pfizer” and others”, says Valerijs
Maligins, Chairman of Olainfarm’s Board.
AS “Olainfarm” launched PASA in 2001. Since then
the company has been delivering this product to special clinical
centres in Latvia, Lithuania, Estonia, Ukraine and Belarus.
In 2007 AS „Olainfarm” was awarded a contract by authorities
of Kazakhstan to supply PASA to national reserves of Kazakhstan.
Value of the contract then was 974 000 lats (1,38 million
euro).
AS “Olainfarm” is the only European producer of PASA,
producing it in a user friendly and comfortable form of sachets for
per-oral use. PASA is an anti-tuberculosis medicine with
bacteriostatic activity against micro-bacteria of tuberculosis. In
combination with other anti-tuberculosis products it is being used
for treatment of different forms and localisations of tuberculosis
if more traditional treatment methods have proven
ineffective.
List of WHO prequalified medicines includes companies
from US, UK, Australia, Latvia, Belgium, RSA, France, Italy, India,
China, Canada, The Netherlands, Spain, Switzerland, Hungary,
Germany and other countries. More detailed information about WHO
programmes is available at:
http://apps.who.int/prequal/default.htm.
A/s Olainfarm is one of the biggest pharmaceutical
companies in Latvia with nearly 40 years of experience in
production of medication and chemical and pharmaceutical products.
A basic principle of company's operations is to produce reliable
and effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
30 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
Member of the Board
A/s „Olainfarm”
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv
|
Pielikumi |
|